Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05383326 · ClinicalTrials.gov registry record
Longitudinal Analysis of the Vaginal Microbiome
A clinical trial, sponsored by Viome.
- Completed
- Registry status
- 29
- Enrollment target
NCT05383326: Completed study, sponsored by Viome.
NCT05383326 is a clinical trial that has completed, run by Viome. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05383326 has completed, sponsored by Viome.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This is a longitudinal, observational study with the goal of understanding vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 women that have regular menstrual cycles and are 18 years of age or older. This study is direct to participant and will NOT utilize clinical sites.
Primary Outcome
A vaginal metatranscriptomic test will be used to analyze the vaginal microbiome taxonomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-07-07 |
| Est. Completion | 2023-08-20 |
What the finished NCT05383326 record still lists
NCT05383326 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05383326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05383326 about?
NCT05383326 is a clinical study titled "Longitudinal Analysis of the Vaginal Microbiome". This is a longitudinal, observational study with the goal of understanding vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 women that have regular menstrual cycles and are 18 years of age or older. This study is direct to pa...
What is the current status of trial NCT05383326?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2022-07-07. Estimated completion is 2023-08-20.
Who is sponsoring clinical trial NCT05383326?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI